Expression profiles of PRKG1, SDF2L1 and PPP1R12A are predictive and prognostic factors for therapy response and survival in high-grade serous ovarian cancer.
Benvenuto G, Todeschini P, Paracchini L, Calura E, Fruscio R, Romani C, Beltrame L, Martini P, Ravaggi A, Ceppi L, Sales G, Donati F, Perego P, Zanotti L, Ballabio S, Grassi T, Delle Marchette M, Tognon G, Sartori E, Adorni M, Odicino F, D'Incalci M, Bignotti E, Romualdi C, Marchini S.
Benvenuto G, et al. Among authors: grassi t.
Int J Cancer. 2020 Jul 15;147(2):565-574. doi: 10.1002/ijc.32935. Epub 2020 Mar 13.
Int J Cancer. 2020.
PMID: 32096871